140 related articles for article (PubMed ID: 10473236)
1. Bactericidal action of oral ampicillin/sulbactam against Mycobacterium leprae.
Randhawa B; Harris EB; Prabhakaran K
J Antimicrob Chemother; 1999 Aug; 44(2):279-81. PubMed ID: 10473236
[TBL] [Abstract][Full Text] [Related]
2. Reversal of drug resistance in Mycobacterium leprae by ampicillin/sulbactam.
Prabhakaran K; Harris EB; Randhawa B; Hastings RC
Microbios; 1992; 72(291):137-42. PubMed ID: 1287401
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal action of ampicillin/sulbactam against Mycobacterium leprae.
Randhawa B; Harris EB; Prabhakaran K; Hastings RC
J Antimicrob Chemother; 1994 May; 33(5):1035-7. PubMed ID: 8089050
[No Abstract] [Full Text] [Related]
4. Bactericidal action of ampicillin/sulbactam against intracellular mycobacteria.
Prabhakaran K; Harris EB; Randhawa B
Int J Antimicrob Agents; 1999 Oct; 13(2):133-5. PubMed ID: 10595573
[TBL] [Abstract][Full Text] [Related]
5. Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents.
Prabhakaran K; Harris EB; Randhawa B; Adams LB; Williams DL; Hastings RC
Microbios; 1993; 76(309):251-61. PubMed ID: 8302203
[TBL] [Abstract][Full Text] [Related]
6. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the multiplication of Mycobacterium leprae in nude mice by intermittent administration of a new rifamycin derivative, 3'-hydroxy-5'-(4-isobutyl-1-piperazinyl)benzoxazinorifamycin (KRM-1648) combined with sparfloxacin.
Gidoh M; Matsuki G; Tsutsumi S; Hidaka T; Nakamura S
Lepr Rev; 1995 Mar; 66(1):39-47. PubMed ID: 7731340
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
Herbert D; Paramasivan CN; Venkatesan P; Kubendiran G; Prabhakar R; Mitchison DA
Antimicrob Agents Chemother; 1996 Oct; 40(10):2296-9. PubMed ID: 8891133
[TBL] [Abstract][Full Text] [Related]
9. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
Hastings RC; Richard V; Christy SA; Morales MJ
Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
[TBL] [Abstract][Full Text] [Related]
10. The activity of amoxicillin plus clavulanic acid against Mycobacterium leprae in mice.
Gelber RH
J Infect Dis; 1991 Jun; 163(6):1374-7. PubMed ID: 2037803
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the bactericidal activity of ampicillin/sulbactam and erythromycin against intracellular Legionella pneumophila.
Ramirez JA; Summersgill JT; Miller RD; Meyers TL; Raff MJ
J Antimicrob Chemother; 1993 Jul; 32(1):93-9. PubMed ID: 8226420
[TBL] [Abstract][Full Text] [Related]
12. [The combined preparation ampicillin/sulbactam (Unasyn) in the general surgical clinic].
Bogomolova NS; Bronskaia LK
Antibiot Khimioter; 1991 Jun; 36(6):15-8. PubMed ID: 1898182
[No Abstract] [Full Text] [Related]
13. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Ji B; Perani EG; Petinon C; Grosset JH
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
[TBL] [Abstract][Full Text] [Related]
14. Leprosy resistant to multi-drug-therapy (MDT) successfully treated with ampicillin-sulbactam combination--(a case report).
Mehta VR
Indian J Med Sci; 1996 Nov; 50(11):305-7. PubMed ID: 9141351
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium leprae is naturally resistant to PA-824.
Manjunatha UH; Lahiri R; Randhawa B; Dowd CS; Krahenbuhl JL; Barry CE
Antimicrob Agents Chemother; 2006 Oct; 50(10):3350-4. PubMed ID: 17005816
[TBL] [Abstract][Full Text] [Related]
16. Sulbactam/ampicillin followed by oral treatment with sultamicillin for medical and surgical infections.
Chang ST; Chung HY; Pai SD; Lee JH
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):175S-178S. PubMed ID: 2686917
[TBL] [Abstract][Full Text] [Related]
17. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
Holmes IB
Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
[No Abstract] [Full Text] [Related]
18. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Friedel HA; Campoli-Richards DM; Goa KL
Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
[TBL] [Abstract][Full Text] [Related]
19. Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
Guelpa-Lauras CC; Perani EG; Giroir AM; Grosset JH
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):70-7. PubMed ID: 3549940
[TBL] [Abstract][Full Text] [Related]
20. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
Holmes IB; Hilson GR
J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
